Fracture Risk After Initiation of Use of Canagliflozin
Ann Intern Med
.
2019 Jul 2;171(1):80.
doi: 10.7326/L19-0320.
Authors
Michael Fralick
1
,
Seoyoung C Kim
1
,
Sebastian Schneeweiss
1
,
Dae Kim
1
,
Donald A Redelmeier
2
,
Elisabetta Patorno
1
Affiliations
1
Brigham and Women's Hospital, Boston, Massachusetts (M.F., S.C.K., S.S., D.K., E.P.).
2
Sunnybrook Health Sciences, Toronto, Ontario, Canada (D.A.R.).
PMID:
31261403
DOI:
10.7326/L19-0320
No abstract available
Publication types
Letter
Comment
MeSH terms
Canagliflozin
Cohort Studies
Fractures, Bone*
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors*
Substances
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin